Advancements in MRI-based biomarkers for inflammatory myopathies emphasize the need for accurate diagnosis
Increased cardiovascular risk associated with polymyositis, rare presentations of giant cell myositis, and the implications of anti-cancer drug treatments on neuromuscular health
